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Abstract
Background: Adiponectin is an adipocyte hormone involved in energy homeostasis and metabolism. However,
its role in early infancy is poorly understood.
Methods: We recruited a total of 443 pregnant women and their children in this prospective study. Cord blood
samples were successfully obtained from 331 neonates. Maternal and umbilical blood serum adiponectin were measured.
The weight-, height- and BMI-for-age Z scores of infants at birth and at 3, 6 and 12 months of age were assessed.
Results: Multiple linear regression analysis indicated that cord blood but not maternal serum adiponectin was positively
associated with all of the anthropometric measures at birth (P < 0.01). Using Generalized Estimating Equation model after
adjustment for sex, time, maternal age, gestational age, prepregnancy BMI, weight gain during pregnancy, maternal
education, parity, history of miscarriage and mode of delivery, for every 1-μg/ml increment of maternal serum
adiponectin, the height-for-age Z score during the first year of life increased by 0.026 (P =0.013) on average, and
the height-for-age Z score of infants in the highest quartile of maternal serum adiponectin was 0.270 (95 % CI:
0.013–0.527) higher than those in the lowest quartile. The changes in weight-for-age Z score from birth decreased by
0.67 × 10−2 on average with every 1-μg/ml additional increase of cord blood adiponectin (P = 0.047). The infants in the
highest quartile of cord blood adiponectin showed a −0.368 (95 % CI, −0.701–−0.035) decrease in weight-for-age Z
score change from birth compared with those in the lowest quartile.
Conclusions: Cord blood adiponectin concentration is a determinant of infant birth size and weight gain in the first
year of life. Circulating maternal adiponectin during pregnancy may predict postnatal height growth.
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Background
Obesity has received considerable attention as a major
health threat with several etiologic influences [1]. Observa-
tional evidence suggests that a high birth weight and accel-
erated growth in infancy are associated with an increased
risk of obesity in childhood and adulthood [2, 3]. Accumu-
lating evidence indicates that the development of obesity
and its comorbidities may be influenced by intrauterine
factors [4].
Adiponectin is an adipokine that is secreted by adipose
tissue and correlates inversely with obesity in adults [5].
It is also abundantly present in the cord blood of term
neonates, at concentrations two to three times higher
than those reported in adults [6]. However, studies to
date have yielded markedly conflicting results on the re-
lationship between maternal serum/cord blood adipo-
nectin concentration and infant birth weight, ranging
from an inverse association to no correlation to even a
positive relationship [7–9]. Relatively few studies have
evaluated the longer-term relationships of adiponectin
level with growth [8, 10]. Different ethnicities show var-
ied levels of adiponectin [11], and the effect of pharma-
cologic agents that work by altering adiponectin levels
also differs by ethnic group [12]. Studies in adults have
established that ethnicity modifies the relationship be-
tween adiponectin and obesity, which may be partly due
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to differences in fat distribution particularly in the visceral
compartment, the capacity for fat storage, genetic back-
ground and differential exposure to important environ-
mental influences [12–14]. It is possible that ethnicity
alters the relationship between adiponectin concentration
and infant growth. Therefore, what applies to other ethnic
populations might not apply to the Chinese population.
However, up to now, no studies have been conducted to
evaluate the effects of maternal and umbilical blood adi-
ponectin levels on the postnatal growth of children in
China. Additionally, most existing studies have estimated
differences in adiponectin circulation associated with a
change in anthropometric measures between two time
points only, rather than with trajectories estimated from
multiple measures of growth.
The primary aim of this study was to determine whether
maternal and cord blood adiponectin levels are related to
the growth of children in early infancy in China.
Subjects and Methods
Subjects
The subjects were 443 pregnancy women aged 20–35 and
their babies from a prospective cohort study in Guangzhou,
China. They were recruited from the Maternal and Chil-
dren’s Hospital of BaiYun and Yuexiu District, Guangzhou
between September 2010 and November 2011. All of the
women had delivered normal single infants at full term. We
excluded those with multiple births, a history of diabetes,
chronic hypertension, endocrine disorders and /or other
severe maternal illnesses. A detailed explanation of the
study purposes, procedure and requirements was given to
the subjects. Written informed consent was obtained from
all the subjects before enrolment. The study protocol was
approved by the research ethics board of Tongji Medical
College, China.
Data collection
Clinical and demographic data
An interviewer-administered questionnaire was used to col-
lect the demographic and historical information of the sub-
jects, including their educational status, household income,
personal medical and obstetrical history, information about
their current pregnancy (including the delivery type, gesta-
tional duration, gender of the baby, the weight gain during
pregnancy, and maternal pre-pregnancy weight) and height.
Anthropometric measurements
After delivery, maternal height was measured to the nearest
0.1 cm and weight to the nearest 0.5 kg while the subjects
were wearing light clothing and no shoes. Measurements of
the infants’ weight (±0.1 kg) and length (±0.1 cm) were
made at birth and at 3, 6, and 12 months of age (+/−
15 days) according to standardised techniques by using an
infant stadiometer (length board) and infant digital scale.
Body mass index (BMI) was calculated as weight (kilo-
gram)/height in meters square.
Adiponectin concentrations
Venous blood samples of mothers were obtained in the
morning after overnight fasting when they were admit-
ted to the hospital awaiting delivery. A total of 331 cord
blood samples were successfully collected from the um-
bilical vein after the delivery of the baby and before the
delivery of the placenta. All of the blood samples were
placed on ice packs, stored in styrofoam containers, and
returned to our laboratory. On arrival, the blood samples
were centrifuged and aliquoted, and frozen at −80 °C until
analysis. The adiponectin in the serum was determined by
a commercially available ELISA (R&D Systems, Wiesbaden,
Germany). The intra- and interassay coefficients of vari-
ation were 5.4 and 7.0 %, respectively.
Statistical analysis
All analyses were conducted using SPSS 21.0 for Windows
(SPSS, Inc., Chicago, USA). P < 0.05 was considered sig-
nificant. All continuous variables were expressed as mean
± standard deviation, or median with inter-quartile range.
They were checked for normality using the Kolmogorov–
Smirnoff test. Categorical variables are presented as
percentages.
The age- and sex-specific weight-, height- and BMI-for
age Z-scores were generated based on the WHO stan-
dards [15]. Two multiple linear regression models using
the enter method were applied to examine whether the
correlations between the adiponectin level and body size
measurements at birth were independent after adjust-
ment for other potential covariates. In model 1, we ad-
justed for sex. And in model 2, we further adjusted for
maternal age, gestational age, prepregnancy BMI, weight
gain during pregnancy, maternal education, parity, his-
tory of miscarriage and mode of delivery. We did not log
transform adiponectin since its residual plot did not in-
dicate any violations of the linear regression model as-
sumptions. The Generalized Estimating Equation (GEE)
method with unstructured correlation matrix was used
to estimate the relationship between the maternal and
cord blood adiponectin levels and the weight-, height-
and BMI-for age Z-scores at 3, 6 and 12 months of age,
and their average changes from birth. This technique is
applied to the analysis of longitudinal data that are an
extension of generalised linear models, and was specially
developed to account for autocorrelation due to serial
measurements [16]. Analyses of the relationship between
maternal/cord blood adiponectin concentration and an-
thropometric indicators and their changes at 3, 6 and
12 months of age were serially adjusted for confounding
factors in two generalized estimating equation models: that
is, a model adjusted for sex and time only; and a model
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adjusted for maternal age, gestational age, prepregnancy
BMI, weight gain during pregnancy, maternal education,
parity, history of miscarriage and mode of delivery in
addition to sex and time. The adiponectin level was entered
as either a continuous or a four-level categorical variable.
Results
Selected characteristics of the study subjects
Table 1 summarizes the characteristics of the study popu-
lation and neonatal outcomes. The mean age of the study
participants was 27.3 years and the median prepregnancy
BMI was 19.8 kg/m2. The median increase in weight at
the end of pregnancy was 15.0 kg. Fifty-two percent of the
neonates were male. The median neonatal gestational age
was 39.0 weeks. The adiponectin levels were signifi-
cantly higher in the cord blood than in maternal serum
(39.6 μg/ml vs. 6.9 μg/ml, P < 0.05). After adjustment for
gestational age, weight gain during pregnancy and age, a
weak positive correlation (r = 0.172, P = 0.004) was ob-
served in adiponectin levels in maternal vs. fetal circula-
tion. The anthropometric parameters at each visit are
showed in Additional file 1: Table S1. In general, the
weight-, height- and BMI-for-age Z scores at birth were
lower than the reference but higher at 3, 6 and 12 months
(Additional file 1: Figure S1).
Adiponectin level and neonatal weight-, height- and
BMI-for-age Z score
There were significant inverse associations between cord
blood serum adiponectin level and the neonatal weight-,
height- and BMI-for age Z scores (Table 2). After control-
ling for sex, maternal age, gestation age, prepregnancy
BMI, weight gain during pregnancy, maternal education,
parity, history of miscarriage and mode of delivery, for
every 1-μg/ml increase in cord blood adiponectin, the
weight-for-age Z score at birth increased by 1.00 × 10-2
(P < 0.0001). Equivalent estimations of height- and BMI-
for-age Z score at birth were 0.69 × 10-2 (P = 0.010) and
1.02 × 10-2 (P = 0.002), respectively. No significant relation-
ships were detected between maternal serum adiponectin
circulation and fetal anthropometrics.
Adiponectin level and anthropometric measures and
their changes after birth
The GEE analysis of the associations between maternal
and cord blood adiponectin and the weight-, height-
and BMI-for age Z scores and their changes at 3, 6 and
12 months are shown in Table 3. After controlling for
sex, time, maternal age, gestation age, prepregnancy BMI,
weight gain during pregnancy, maternal education, parity,
history of miscarriage and mode of delivery, for every
1-μg/ml additional increase of maternal blood adipo-
nectin, the height-for-age Z score increased by 2.59 × 10−2
on average during the follow-up period (P = 0.013). And
the changes in weight-for-age Z score decreased by 0.67 ×
10−2 with every 1-μg/ml increment of cord blood adipo-
nectin (P = 0.047).
When the maternal blood serum adiponectin levels
were ranked in quartiles, the height-for-age Z score of in-
fants in the highest quartile of maternal serum adiponec-
tin was 0.270 (95 % CI: 0.013–0.527) higher than that in
the lowest quartile (Fig. 1) after adjustment for covariates
as mentioned above. Figure 2 demonstrates the associa-
tions between the quartiles for cord blood serum adiponec-
tin and changes in the anthropometrics Z score. Infants in
the highest quartile of cord blood adiponectin showed a
−0.368 (95 % CI, −0.701–−0.035) decrease in weight-for-
age Z score change and a −0.395 (−0.784–−0.006) decrease
in BMI-for-age Z score compared with the lowest quartile.
No differences were found in the changes in body size Z
scores from birth among the quartiles for maternal serum
adiponectin or in the body size Z scores themselves among
the quartiles of cord blood adiponectin (data not shown).
Table 1 Characteristics of the subjects
Variables Mean ± SD/Median (IQR)
Maternal variables
Age at enrolment (year) 27.3 ± 4.2
Pregnancy BMI (kg/m2) 19.8 (2.9)
Weight gain during pregnancy (kg) 15.0 (6.0)
Caesarean section (%) 47.9
Education (%)
Junior high school or less 41.2
Senior middle school 32.4









Maternal serum adiponectin (μg/ml) 6.9 (5.3)
Newborn/infant variables
Male (%) 52.2
Length of gestation (weeks) 39 (2)
Birth weight (g) 3250 (480)
Birth length (cm) 50.0 (1.0)
Birth BMI (kg/m2) 13.1 ± 1.2
Cord adiponectin (μg/ml) 39.6 (20.1)
BMI: body mass index; SD: standard deviation; IQR: inter-quartile range
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Discussion
This prospective study is the first to report the influence
of maternal and cord blood adiponectin levels on neo-
natal weight-, height- and BMI-for-age Z score at birth
and their changes at 3, 6 and 12 months of age. The
main finding of our study is that cord blood adiponectin
was positively associated with anthropometric measures
at birth but inversely correlated with weight-for-age Z
score changes from baseline during the first year of life
after adjustment for potential covariates. Maternal blood
adiponectin concentrations were significantly lower than
those of the umbilical blood and showed a positive rela-
tionship with height-for-age Z score during the first year
of life.
Table 2 Multiple linear regression analysis of the associations between maternal and cord blood adiponectin levels and weight-,
height-, and BMI-for-age z scores at birth
Maternal blood APN Cord blood APN
β (×10−2) SE (×10−2) P β (×10−2) SE (×10−2) P
Weight-for-age Z score
Model 1 −1.27 0.91 0.162 1.33 0.28 <0.0001
Model 2 −0.41 0.79 0.610 1.00 0.25 <0.0001
Height- for-age Z score
Model 1 −0.27 0.87 0.755 1.00 0.27 <0.001
Model 2 0.44 0.84 0.598 0.69 0.27 0.010
BMI-for-age Z score
Model 1 −1.72 1.10 0.117 1.25 0.33 <0.001
Model 2 −0.81 1.00 0.419 1.02 0.32 0.002
Model 1: Adjusted by sex
Model 2: Adjusted by sex, maternal age, gestation age, prepregnancy BMI, weight gain in pregnancy preceding, maternal education, parity, history of miscarriage
and mode of delivery, Method: entered
Table 3 GEE analysis of the associations between maternal and cord blood adiponectin levels and the anthropometric parameters
and their changes from birth during the first year of life
Maternal blood APN Cord blood APN
β (×10−2) SE (×10−2) P β (×10−2) SE (×10−2) P
Weight-for-age Z score
Model 1 1.35 0.83 0.107 0.63 0.29 0.030
Model 2 1.63 0.81 0.044 0.36 0.28 0.199
Height-for-age Z score
Model 1 2.48 1.04 0.017 0.52 0.32 0.105
Model 2 2.59 1.05 0.013 0.19 0.32 0.560
BMI-for-age Z score
Model 1 −0.27 0.72 0.709 0.59 0.28 0.034
Model 2 0.33 0.70 0.641 0.44 0.27 0.110
Changes in weight-for-age Z score
Model 1 2.62 1.02 0.010 −0.68 0.35 0.048
Model 2 1.92 0.99 0.051 −0.67 0.34 0.047
Changes in height-for-age Z score
Model 1 2.77 1.28 0.030 −0.55 0.34 0.099
Model 2 2.09 1.29 0.105 −0.50 0.33 0.120
Changes in BMI-for-age Z score
Model 1 1.78 1.07 0.090 −0.65 0.41 0.112
Model 2 1.19 1.02 0.244 −0.62 0.41 0.128
Model 1: Adjusted by sex and time
Model 2: Adjusted by sex, time, maternal age, gestation age, prepregnancy BMI, weight gain in pregnancy, maternal education, parity, history of miscarriage and
mode of delivery
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We confirm data from previous observational studies
showing that cord blood adiponectin levels were several
folds higher than those seen in adults [17, 18]. The recent
study of Luo et al. observed a statistically significant posi-
tive correlation in adiponectin levels in maternal and fetal
circulation (r = 0.3, P < 0.0001) [19]. A significant positive
correlation in adiponectin levels in maternal vs. fetal circu-
lation adjusted by covariates was also detected in our data
(r = 0.172, P = 0.004). Genetic variation in the adiponectin
gene or its regulating elements may be responsible for this
maternal-fetal correlation. In contrast, only nonstatistically
significant positive correlations have been reported in
most previous studies [6, 20, 21]. Insufficient study power
in some studies (n = 51–74) [20, 21] and differences in the
adjustment for potential confounders may partly explain
the null findings in previous studies.
The positive correlation between cord blood adiponec-
tin and fetal anthropometrics in our study is in agreement
with some studies [6, 8, 21] but not all [22, 23]. Several
factors may explain the lack of consistency in this regard.
In the study of Lindsay et al., the absence of a significant
association may be explained by the confounding effect of
the existence of pre-disease states in some of the individ-
uals included in the populations that were studied [9]. The
other studies were limited by a small sample size (44–74),
and thus they may have missed associations due to a lack
of statistical power [20, 22, 23]. Additionally, studies in
adults have indicated that the correlations between adipo-
nectin and adiposity are modulated by ethnicities [12].
Whether ancestral background also accounts for dispar-
ities in the relationship between adiponectin and obesity
in neonates needs to be further elucidated.
A few prospective studies have been conducted on the
role of cord and maternal blood adiponectin levels in the
postnatal growth of infants. In a sample of 588 children
participating in the prospective prebirth cohort study
Project Viva, Mantzoros et al. reported that cord blood
adiponectin was inversely correlated with change in
weight-for-length Z score (r = −0.12; P = 0.05) and weight-
for-age Z score (r = −0.10; P = 0.04) from birth to 6 months
but was not associated with change in length-for-age Z
score (r = 0.03; P = 0.61) [10]. In agreement with the find-
ings of Mantzoros et al. [10], we also found that neonates
with a higher cord blood adiponectin gained less weight
during the first year of life.
Most previous epidemiologic studies investigating the
links between adiponectin levels and obesity in adults
and children have demonstrated a negative relationship
[24]. In fetal tissue, adiponectin is secreted not only by
adipocytes, but also muscle and vascular cells, whereas
in adult humans it is exclusively secreted by adipose tis-
sue [25]. Fetal adipose tissue is also composed mainly of
small newly differentiated adipocytes that lack the factors
that are responsible for the inhibition of adiponectin pro-
duction. Several lines of evidence suggest that senescent
cells could accumulate in fat tissue with chronological
aging and that these cells might contribute to age-related
fat tissue inflammation and dysfunction [26]. Addition-
ally, the available data suggest that brown adipose tis-
sue (BAT) is more prevalent in children than in adults
[27]. It is under strikingly different hormonal regulation
than in white adipose tissue [28]. Moreover, adiponec-
tin secretion from omental but not from sc adipocytes
Fig. 1 GEE analysis of the relationship between quartiles of maternal
serum adiponectin and body-size Z score during the first year of life
after adjustment for sex, time, maternal age, gestation age, prepregnancy
BMI, weight gain during pregnancy, maternal education, parity, history of
miscarriage and mode of delivery. Weight-for-age Z score: ●; Height-for-
age Z score: ■; BMI-for-age Z score:▲; *: P < 0.05. β values represent
difference in body size Z score with the reference category, i.e., lowest
quartile of adiponectin
Fig. 2 GEE analysis of the relationship between quartiles of cord
blood adiponectin and body-size Z score changes from birth during
the first year of life after adjustment for sex, time, maternal age,
gestation age, prepregnancy BMI, weight gain in pregnancy preceding,
maternal education, parity, history of miscarriage and mode of delivery.
Weight-for-age Z score: ●; Height-for-age Z score: ■; BMI-for-age
Z score: ▲; *: P < 0.05. β values represent difference in body size Z
score change with the reference category, i.e., lowest quartile
of adiponectin
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was negatively associated with measures of adiposity
[29, 30]. The different origination of adiponectin, a de-
creasing sc adipose tissue/visceral adipose tissue ratio, the
atrophy of brown adipose tissue and metabolic function
changes in adipocytes with increasing age may in part ex-
plain the switch from a positive correlation between adi-
ponectin and weight at birth to a negative correlation later
in life [21, 28, 31]. In the Nurses’ Health Study, elevated
adiponectin levels at baseline were associated with greater
weight gain in healthy women [32], which is contrary to
our findings in infants. The authors of the Nurses’ Health
Study hypothesized that elevated adiponectin levels in
humans was a sign of healthy adipose tissue and its cap-
acity to adapt to more fat accumulation [32]. However,
cellular stress and adipocyte overutilization with ageing
led to metabolic dysfunction [26]. The variation in the
metabolic function of adipocytes such as fat storage, the
secretion and response to the modulation of adiponectin
may collectively contribute to the discrepancies between
infants and adults. In addition, BAT is especially abundant
during infancy and its activation protects against weight
gain [33]. Additional studies are required to determine
whether BAT modulates weight changes by altering the
secretion of adiponectin. Furthermore, some evidence
suggested that adiponectin could reduce food intake
and increase energy expenditure through action on the
hypothalamus, which also provided a potential explan-
ation for the negative association between cord adipo-
nectin and weight gain [34].
The association between maternal adiponectin concen-
tration and fetal growth are less clear. A negative correl-
ation with birth weight has been reported by some studies
[7], but not others [35, 36]. In this study, maternal adipo-
nectin level was not a determinant of fetal size at birth, but
was positively correlated with the height-for-age Z score
during the first year after adjustment for cofounders. In
theory, maternal adiponectin is unable to pass through the
placental barrier due to its large molecular weight. How-
ever, Aye et al. [37] and Rosario et al. [38] have reported
that adiponectin infusion in pregnant mice downregulates
placental amino acid transporter activity and expression
and decreases fetal growth. Thus, it is possible that ma-
ternal adiponectin circulation potentially modulates
placental function, which, in turn, may affect the intra-
uterine environment of the foetus and the postnatal
growth of infants. Further human studies are warranted
to verify this hypothesis.
The strength of our study is its prospective design and re-
peated measures of anthropometric parameters in infants.
We are the first to report the associations between adipo-
nectin concentrations in maternal and umbilical blood and
infant growth in early infancy in a Chinese population.
However, our study has some limitations. First, not all of
the subjects consented to the assessment of umbilical
adiponectin status; thus, the results may be subject to
potential bias. Second, the results may not be easy to
generalize to other ethnic groups. Third, similar to all
other previous studies, we did not determine fat mass
directly, and did not measure the centrality of fat distri-
bution. Thus, it remains unknown whether there is a
relationship between adiponectin and visceral fat in infants.
Finally, anthropometric measures during the follow-up had
about 5.3–6.0 % missing data in our study. However,
analyses after multiple imputation of the missing values
yielded similar findings and thus our findings were not
biased by the missing data.
Conclusions
Cord blood adiponectin is a determinant of fetal size at
birth and weight gain during the first year of life. Ma-
ternal serum adiponectin during pregnancy may predict
postnatal height growth.
Additional file
Additional file 1: Table S1. The anthropometric measures at 3, 6 and
12 months of the infants. Figure S1. The Mean (SD) of weight-, height-,
and BMI-for-age z scores at 0, 3, 6, 12 months of age. (DOC 190 kb)
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